SINCE I addressed a preliminary memoir to you on this subject, 1 so much curious matter has reached me that I trust you will permit me to state my views afresh, and to deduce some inferences.

ABSTRACT: Although the use of intermediate clinical endpoint or surrogate (correlate) of protection (CoP) has increased over the years, the validation of CoP for high efficacy vaccine trials has ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Department of Physics, Engineering Research Center for Micro−Nano Optoelectronic Materials and Devices of Ministry of Education, OSED, Fujian Provincial Key Laboratory of Semiconductor Materials and ...